169 related articles for article (PubMed ID: 26108997)
1. Targeting DNA-PKcs increased anticancer drug sensitivity by suppressing DNA damage repair in osteosarcoma cell line MG63.
Li X; Tian J; Bo Q; Li K; Wang H; Liu T; Li J
Tumour Biol; 2015 Dec; 36(12):9365-72. PubMed ID: 26108997
[TBL] [Abstract][Full Text] [Related]
2. Wortmannin potentiates the combined effect of etoposide and cisplatin in human glioma cells.
Pastwa E; Poplawski T; Lewandowska U; Somiari SB; Blasiak J; Somiari RI
Int J Biochem Cell Biol; 2014 Aug; 53():423-31. PubMed ID: 24953561
[TBL] [Abstract][Full Text] [Related]
3. Concordant and opposite roles of DNA-PK and the "facilitator of chromatin transcription" (FACT) in DNA repair, apoptosis and necrosis after cisplatin.
Sand-Dejmek J; Adelmant G; Sobhian B; Calkins AS; Marto J; Iglehart DJ; Lazaro JB
Mol Cancer; 2011 Jun; 10():74. PubMed ID: 21679440
[TBL] [Abstract][Full Text] [Related]
4. DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair.
Li Y; Li H; Peng W; He XY; Huang M; Qiu D; Xue YB; Lu L
Mol Med Rep; 2015 Jul; 12(1):1328-34. PubMed ID: 25815686
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting DNA-PK
Mamo T; Mladek AC; Shogren KL; Gustafson C; Gupta SK; Riester SM; Maran A; Galindo M; van Wijnen AJ; Sarkaria JN; Yaszemski MJ
Biochem Biophys Res Commun; 2017 Apr; 486(2):307-313. PubMed ID: 28300555
[TBL] [Abstract][Full Text] [Related]
6. Repair of radiation damage of U2OS osteosarcoma cells is related to DNA-dependent protein kinase catalytic subunit (DNA-PKcs) activity.
Tang X; Yuan F; Guo K
Mol Cell Biochem; 2014 May; 390(1-2):51-9. PubMed ID: 24390088
[TBL] [Abstract][Full Text] [Related]
7. Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair.
Gustafsson AS; Abramenkovs A; Stenerlöw B
Mutat Res; 2014 Nov; 769():1-10. PubMed ID: 25771720
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of beclin1 affects the chemotherapeutic sensitivity of osteosarcoma.
Wu W; Li W; Zhou Y; Zhang C
Int J Clin Exp Pathol; 2014; 7(10):7114-22. PubMed ID: 25400807
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ERK activation enhances the repair of double-stranded breaks via non-homologous end joining by increasing DNA-PKcs activation.
Wei F; Yan J; Tang D; Lin X; He L; Xie Y; Tao L; Wang S
Biochim Biophys Acta; 2013 Jan; 1833(1):90-100. PubMed ID: 23098854
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines.
Nishida Y; Mizutani N; Inoue M; Omori Y; Tamiya-Koizumi K; Takagi A; Kojima T; Suzuki M; Nozawa Y; Minami Y; Ohnishi K; Naoe T; Murate T
Biochim Biophys Acta; 2014; 1839(4):265-74. PubMed ID: 24530422
[TBL] [Abstract][Full Text] [Related]
11. Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells.
Zhen YF; Li ST; Zhu YR; Wang XD; Zhou XZ; Zhu LQ
Oncotarget; 2016 Nov; 7(48):79417-79427. PubMed ID: 27765904
[TBL] [Abstract][Full Text] [Related]
12. DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma?
Pascale RM; Joseph C; Latte G; Evert M; Feo F; Calvisi DF
DNA Repair (Amst); 2016 Nov; 47():12-20. PubMed ID: 27789167
[TBL] [Abstract][Full Text] [Related]
13. Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition.
Middleton FK; Patterson MJ; Elstob CJ; Fordham S; Herriott A; Wade MA; McCormick A; Edmondson R; May FE; Allan JM; Pollard JR; Curtin NJ
Oncotarget; 2015 Oct; 6(32):32396-409. PubMed ID: 26486089
[TBL] [Abstract][Full Text] [Related]
14. Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair.
Toulany M; Lee KJ; Fattah KR; Lin YF; Fehrenbacher B; Schaller M; Chen BP; Chen DJ; Rodemann HP
Mol Cancer Res; 2012 Jul; 10(7):945-57. PubMed ID: 22596249
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of DNA-PKcs suppresses P-gp expression via inhibition of the Akt/NF-κB pathway in CD133-positive osteosarcoma MG-63 cells.
Li K; Li X; Tian J; Wang H; Pan J; Li J
Oncol Rep; 2016 Oct; 36(4):1973-80. PubMed ID: 27499034
[TBL] [Abstract][Full Text] [Related]
16. [DNA-PKcs silencing inhibit the DNA repair induced by low dose radiation on human breast epithelial cells].
Zou W; Che J; Wang C; Cui Y; Zhang Q
Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):727-32. PubMed ID: 19670642
[TBL] [Abstract][Full Text] [Related]
17. KU70/80, DNA-PKcs, and Artemis are essential for the rapid induction of apoptosis after massive DSB formation.
Abe T; Ishiai M; Hosono Y; Yoshimura A; Tada S; Adachi N; Koyama H; Takata M; Takeda S; Enomoto T; Seki M
Cell Signal; 2008 Nov; 20(11):1978-85. PubMed ID: 18674614
[TBL] [Abstract][Full Text] [Related]
18. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
19. NOTCH1 modulates activity of DNA-PKcs.
Adamowicz M; d'Adda di Fagagna F; Vermezovic J
Mutat Res; 2018 Mar; 808():20-27. PubMed ID: 29482073
[TBL] [Abstract][Full Text] [Related]
20. The relationship between the down-regulation of DNA-PKcs or Ku70 and the chemosensitization in human cervical carcinoma cell line HeLa.
Tian X; Chen G; Xing H; Weng D; Guo Y; Ma D
Oncol Rep; 2007 Oct; 18(4):927-32. PubMed ID: 17786356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
